Back to News
Market Impact: 0.3
McKesson Extends CVS Health Pact To 2032, Reaffirms FY27 Adj. EPS Guidance
Source: Nasdaq
Healthcare & BiotechTransportation & LogisticsCompany Fundamentals
McKesson announced an agreement in principle to extend its partnership with CVS Health to supply medicines to CVS's mail-order, specialty and retail pharmacies, as well as distribution centers. The extension supports continuity of a significant pharmaceutical-distribution relationship and is modestly positive for McKesson's distribution volumes and customer retention.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
CVS0.45
MCK0.55
More News
- One of our most recent defensive buys cleared a hurdle and its stock jumped
- Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock
- Why McKesson Stock Soared More Than 5% Higher Today
- Why is McKesson stock rallying today?
- Cardinal Health rises on extended CVS distribution deal
- Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more